Paper26316468
Design, synthesis and biological evaluation of multifunctional ligands targeting opioid and bradykinin 2 receptors.
Deekonda S and 5 others. Bioorg Med Chem Lett, 2015. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Design, synthesis and biological evaluation of multifunctional ligands targeting opioid and bradykinin 2 receptors. Papers, record 26316468. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26316468
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Design, synthesis and biological evaluation of multifunctional ligands targeting opioid and bradykinin 2 receptors.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bradykinin B2 Receptor Antagonists | Major topic |
| Drug Design | Major topic |
| Oligopeptides | Major topic |
| Receptor, Bradykinin B2 | Major topic |
| Receptors, Opioid | Major topic |
| Animals | |
| Brain | |
| Dose-Response Relationship, Drug | |
| Guinea Pigs | |
| HEK293 Cells | |
| Humans | |
| Ligands | |
| Molecular Structure | |
| Rabbits | |
| Rats | |
| Structure-Activity Relationship |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P01 DA006284 | NIDA NIH HHS | United States | P01DA006284 | PubMed and NIH | NIH RePORTER |
| R01 DA013449 | NIDA NIH HHS | United States | R01DA013449 | PubMed and NIH | NIH RePORTER |
| 2P01 DA006284 | NIDA NIH HHS | United States | P01DA006284 | PubMed and NIH | NIH RePORTER |
| 314450 | PHS HHS | United States | PubMed | PubMed |
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11137228 | Ala scan analogues of HOE 140. Synthesis and biological activities. | Eur J Med Chem | 2000 | https://conductscience.org/library/papers/11137228 | PubMed |
| 2 | 24742335 | Discovery of amphipathic dynorphin A analogues to inhibit the neuroexcitatory effects of dynorphin A through bradykinin receptors in the spinal cord. | J Am Chem Soc | 2014 | https://conductscience.org/library/papers/24742335 | PubMed |
| 3 | 1152600 | An endogenous morphine-like factor in mammalian brain. | Life Sci | 1975 | https://conductscience.org/library/papers/1152600 | PubMed |
| 4 | 1364851 | Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies. | Br J Pharmacol | 1991 | https://conductscience.org/library/papers/1364851 | PubMed |
| 5 | 7893946 | Bradykinin antagonists: development and applications. | Biopolymers | 1995 | https://conductscience.org/library/papers/7893946 | PubMed |
| 6 | 8759638 | Synthesis and characterization of pseudopeptide bradykinin B2 receptor antagonists containing the 1,3,8-triazaspiro[4.5]decan-4-one ring system. | J Med Chem | 1996 | https://conductscience.org/library/papers/8759638 | PubMed |
| 7 | 15734727 | International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. | Pharmacol Rev | 2005 | https://conductscience.org/library/papers/15734727 | PubMed |
| 8 | 25434001 | Modification of amphipathic non-opioid dynorphin A analogues for rat brain bradykinin receptors. | Bioorg Med Chem Lett | 2015 | https://conductscience.org/library/papers/25434001 | PubMed |
| 9 | 18450375 | Pronociceptive actions of dynorphin via bradykinin receptors. | Neurosci Lett | 2008 | https://conductscience.org/library/papers/18450375 | PubMed |
| 10 | 14754373 | Opioid receptors and their ligands. | Curr Top Med Chem | 2004 | https://conductscience.org/library/papers/14754373 | PubMed |
| 11 | 17115041 | Dynorphin A activates bradykinin receptors to maintain neuropathic pain. | Nat Neurosci | 2006 | https://conductscience.org/library/papers/17115041 | PubMed |
| 12 | 10596848 | Bradykinin antagonists: present progress and future prospects. | Immunopharmacology | 1999 | https://conductscience.org/library/papers/10596848 | PubMed |
| 13 | 16504505 | Bradykinin antagonists modified with dipeptide mimetic beta-turn inducers. | Bioorg Med Chem Lett | 2006 | https://conductscience.org/library/papers/16504505 | PubMed |
| 14 | 18821747 | The importance of micelle-bound states for the bioactivities of bifunctional peptide derivatives for delta/mu opioid receptor agonists and neurokinin 1 receptor antagonists. | J Med Chem | 2008 | https://conductscience.org/library/papers/18821747 | PubMed |
| 15 | 8072371 | Bradykinin receptor types and B2 subtypes. | Life Sci | 1994 | https://conductscience.org/library/papers/8072371 | PubMed |
| 16 | 18974747 | Romiplostim. | Nat Rev Drug Discov | 2008 | https://conductscience.org/library/papers/18974747 | PubMed |
| 17 | 21928837 | Design, synthesis, and biological studies of efficient multivalent melanotropin ligands: tools toward melanoma diagnosis and treatment. | J Med Chem | 2011 | https://conductscience.org/library/papers/21928837 | PubMed |
| 18 | 15134872 | Bradykinin antagonists: discovery and development. | Peptides | 2004 | https://conductscience.org/library/papers/15134872 | PubMed |
| 19 | 6312019 | The spinal cord as a site of opioid effects on gastrointestinal transit in the mouse. | J Pharmacol Exp Ther | 1983 | https://conductscience.org/library/papers/6312019 | PubMed |
| 20 | 1326067 | Topographical requirements for delta opioid ligands: common structural features of dermenkephalin and deltorphin. | Life Sci | 1992 | https://conductscience.org/library/papers/1326067 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42943247 | Opioid Peptide Hybrids as Multifunctional Analgesic Ligands: Emphasis on Intracellular Signaling. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42943247 | PubMed |
| 35916657 | Asymmetric Alkylation of Cyclic Ketones with Dehydroalanine via H-Bond-Directing Enamine Catalysis: Straightforward Access to Enantiopure Unnatural α-Amino Acids. | Chemistry | 2022 | https://conductscience.org/library/papers/35916657 | PubMed |
| 33255641 | Multifunctional Opioid-Derived Hybrids in Neuropathic Pain: Preclinical Evidence, Ideas and Challenges. | Molecules | 2020 | https://conductscience.org/library/papers/33255641 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BDKRB2 | 624 | PubTator's text mining | https://conductscience.org/library/genes/624 | NCBI Gene |
| KNG1 | 3827 | PubTator's text mining | https://conductscience.org/library/genes/3827 | NCBI Gene |
| KRT82 | 3888 | PubTator's text mining | https://conductscience.org/library/genes/3888 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26316468
GET https://conductscience.org/api/papers/v1/26316468/references?page=2